WBIO Stock Overview
Does not have any significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
WPD Pharmaceuticals Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.035 |
| 52 Week Low | CA$0.005 |
| Beta | 0.76 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 33 Year Change | -91.67% |
| 5 Year Change | n/a |
| Change since IPO | -99.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| WBIO | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | 2.2% |
| 1Y | n/a | -5.4% | 23.4% |
Return vs Industry: Insufficient data to determine how WBIO performed against the Canadian Biotechs industry.
Return vs Market: Insufficient data to determine how WBIO performed against the Canadian Market.
Price Volatility
| WBIO volatility | |
|---|---|
| WBIO Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: WBIO's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine WBIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 16 | Mariusz Olejniczak | www.wpdpharmaceuticals.com |
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
WPD Pharmaceuticals Inc. Fundamentals Summary
| WBIO fundamental statistics | |
|---|---|
| Market cap | CA$579.94k |
| Earnings (TTM) | -CA$140.08k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-4.1x
P/E RatioIs WBIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WBIO income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$140.08k |
| Earnings | -CA$140.08k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -50.4% |
How did WBIO perform over the long term?
See historical performance and comparison